| Home > Authorities > Periodicals > Liver cancer > print |
| 001 | 75231 | ||
| 005 | 20250112182113.0 | ||
| 022 | _ | _ | |2 (DE-600)2643364-3 |a 2235-1795 |
| 022 | _ | _ | |a 1664-5553 |l 1664-5553 |
| 022 | _ | _ | |a 2235-1795 |
| 024 | 7 | _ | |2 ZDBID |a PERI:(DE-600)2666925-0 |
| 024 | 7 | _ | |2 ZDBPPN |a ZDPPN:1023385228 |
| 024 | 7 | _ | |2 EZBID |a PERI:(DE-606)184796 |
| 024 | 7 | _ | |2 EZBID |a PERI:(DE-606)184796 |
| 024 | 7 | _ | |2 OCLC |a OCLC:1164173184 |
| 024 | 7 | _ | |2 JCR |a JCR:LIVER CANCER |
| 024 | 7 | _ | |2 ISI |a WOS:LIVER CANCER |
| 024 | 7 | _ | |2 SCOPUS |a SCOPUS:21100782975 |
| 024 | 7 | _ | |2 Medline |a medline:101597993 |
| 035 | _ | _ | |a PERI:(DE-600)2666925-0 |
| 040 | _ | _ | |a 0012 |b ger |c DE-101 |d JOIN² |e JOIN² journal identification |
| 041 | _ | _ | |a eng |
| 044 | _ | _ | |c XA-CH |
| 082 | _ | _ | |2 22sdnb |a 610 |q DE-101 |
| 082 | 7 | 4 | |2 22sdnb |a 610 |q DE-101 |
| 210 | 0 | _ | |2 iso |a Liver Cancer |
| 210 | 0 | _ | |2 dnlm |a Liver Cancer |
| 210 | 0 | _ | |2 iso |a Liver Cancer |
| 242 | 2 | 0 | |2 DE-600 |a Liver cancer |y en |
| 242 | 2 | 0 | |2 DE-600 |a Liver cancer |
| 245 | _ | _ | |2 DE-600 |a Liver cancer |h print, online |
| 246 | 3 | _ | |2 DE-600 |a Liver cancer |
| 260 | _ | _ | |a Basel |b Karger |c 2012- |
| 260 | _ | 1 | |0 Host:(DE-Juel1)86 |2 DE-Juel1 |a Karger |
| 260 | 7 | _ | |2 DOAJ |a Switzerland |b Karger Publishers |d 2024-11-09T15:07:39Z |f Liver Cancer |
| 264 | 3 | 1 | |a Basel |b Karger |c 2012- |
| 362 | 0 | _ | |2 DE-600 |a 1.2012 - |
| 363 | 0 | 1 | |2 DE-600 |8 1.1\x |a 1 |i 2012 |
| 365 | _ | _ | |2 DOAJ |a APC |b 3490 |c CHF |d 2024-11-09T15:07:39Z |
| 380 | _ | _ | |2 marcgt |a journal |
| 500 | _ | _ | |a Automatically generated record. (Updated: 2025-01-02) |
| 650 | _ | 7 | |0 ASJC:2730 |2 ASJC |a Oncology |
| 650 | _ | 7 | |0 ASJC:2721 |2 ASJC |a Hepatology |
| 653 | 1 | 0 | |2 EZB-Subject |a Medizin |
| 653 | 1 | 0 | |2 EZB-Keyword |a Hepatologie,Onkologie |
| 653 | 1 | 0 | |2 DOAJ |a gastroenterology |d 2024-11-09T15:07:39Z |
| 653 | 1 | 0 | |2 DOAJ |a oncology |d 2024-11-09T15:07:39Z |
| 653 | 1 | 0 | |2 DOAJ |a hepatology |d 2024-11-09T15:07:39Z |
| 653 | 1 | 0 | |2 DOAJ |a liver |d 2024-11-09T15:07:39Z |
| 653 | 1 | 0 | |2 DOAJ |a cancer |d 2024-11-09T15:07:39Z |
| 653 | 1 | 0 | |2 DOAJ |a Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens |d 2024-11-09T15:07:39Z |
| 776 | 0 | 8 | |2 DE-600 |d Basel ; Freiburg ; Paris ; London ; New York, NY ; New Delhi ; Bangkok ; Beijing ; Tokyo ; Kuala Lumpur ; Singapore : Karger, 2012-[2019] |i Erscheint auch als |n Druck-Ausgabe |t Liver cancer |w (DE-600)2643364-3 |x 2235-1795 |
| 856 | 4 | _ | |d 0 |u https://ezb.ur.de/?2666925-0 |y EZB |
| 856 | 4 | _ | |d 0 |u https://karger.com/LIC |y Verlag; 1.2012 - 8.2019 = Deutschlandweit zugänglich |
| 856 | 4 | _ | |d 0 |u https://www.karger.com/Journal/Details/255487 |y Scope |
| 856 | 4 | _ | |d 0 |u https://www.karger.com/Journal/EditorialBoard/255487 |y Editorial board |
| 856 | 4 | _ | |d 0 |u https://www.karger.com/Journal/Guidelines/255487 |y Instructions for Authors |
| 856 | 4 | _ | |d 0 |u https://www.karger.com/Journal/Guidelines/255487#sec50 |y Review process |
| 856 | 4 | _ | |d 0 |u https://www.karger.com/Journal/Guidelines/255487#sec62 |y APC information |
| 856 | 4 | _ | |d 0 |u https://www.ncbi.nlm.nih.gov/pmc/journals/2074 |y Archivierung = kostenfrei |
| 880 | 1 | _ | |2 DE-600 |a Liver cancer |
| 909 | C | O | |o oai:juser.fz-juelich.de:163523 |p authority:PERI |p authority |
| 909 | C | O | |o oai:juser.fz-juelich.de:163523 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0420 |2 StatID |a Nationallizenz |d 2025-01-02 |w ger |
| 915 | _ | _ | |0 StatID:(DE-HGF)0200 |2 StatID |a DBCoverage |b SCOPUS |d 2025-01-02 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0300 |2 StatID |a DBCoverage |b Medline |d 2025-01-02 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0501 |2 StatID |a DBCoverage |b DOAJ Seal |d 2024-11-09T15:07:39Z |
| 915 | _ | _ | |0 StatID:(DE-HGF)0500 |2 StatID |a DBCoverage |b DOAJ |d 2024-11-09T15:07:39Z |
| 915 | _ | _ | |0 StatID:(DE-HGF)0030 |2 StatID |a Peer Review |b DOAJ : Anonymous peer review |d 2024-11-09T15:07:39Z |
| 915 | _ | _ | |0 StatID:(DE-HGF)0199 |2 StatID |a DBCoverage |b Clarivate Analytics Master Journal List |d 2025-01-02 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0160 |2 StatID |a DBCoverage |b Essential Science Indicators |d 2025-01-02 |
| 915 | _ | _ | |0 StatID:(DE-HGF)1110 |2 StatID |a DBCoverage |b Current Contents - Clinical Medicine |d 2025-01-02 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0113 |2 StatID |a WoS |b Science Citation Index Expanded |d 2025-01-02 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0150 |2 StatID |a DBCoverage |b Web of Science Core Collection |d 2025-01-02 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0100 |2 StatID |a JCR |b LIVER CANCER : 2022 |d 2025-01-02 |
| 915 | _ | _ | |0 StatID:(DE-HGF)9910 |2 StatID |a IF >= 10 |b LIVER CANCER : 2022 |d 2025-01-02 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0561 |2 StatID |a Article Processing Charges |d 2025-01-02 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0700 |2 StatID |a Fees |d 2025-01-02 |
| 936 | _ | _ | |a Karger Open Access from 2020 |
| 980 | _ | _ | |a PERI |
| 980 | _ | _ | |a AUTHORITY |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|